Diffuse large b-cell lymphoma refractory and Febrile neutropenia

Summary:

Febrile neutropenia is found among people with Diffuse large b-cell lymphoma refractory, especially for people who are male, 60+ old.

The study analyzes which people have Febrile neutropenia with Diffuse large b-cell lymphoma refractory. It is created by eHealthMe based on reports of 105 people who have Diffuse large b-cell lymphoma refractory from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Diffuse large b-cell lymphoma refractory?

Diffuse large b-cell lymphoma refractory (cancer of b cells, a type of white blood cell-relapsed) is found to be associated with 50 drugs and 65 conditions by eHealthMe. Check the latest studies of Diffuse large b-cell lymphoma refractory.

What is Febrile neutropenia?

Febrile neutropenia (fever with reduced white blood cells) is found to be associated with 1,586 drugs and 1,875 conditions by eHealthMe. Check the latest studies of Febrile neutropenia.

On Jul, 09, 2026

105 people who have Diffuse Large B-Cell Lymphoma Refractory and Febrile Neutropenia are studied.

$Would you have Febrile neutropenia when you have Diffuse large b-cell lymphoma refractory?$

Gender of people who have Diffuse large b-cell lymphoma refractory and experienced Febrile neutropenia *:

Click here to view

Age of people who have Diffuse large b-cell lymphoma refractory and experienced Febrile neutropenia *:

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Febrile neutropenia?

- Check whether Febrile neutropenia is associated with a drug or a condition

Related publications that referenced our studies

Yaylaci S, Yilmaz EU, Guclu E, Kumsar NA, Tamer A, Karabay O, "Clozapine-Induced Febrile Neutropenia and Cellulitis", Turkish journal of emergency medicine, 2014 Mar .
Yaylaci S, Yilmaz EU, Guclu E, Kumsar NA, Tamer A, Karabay O, "Clozapine-Induced Febrile Neutropenia and Cellulitis", Turkish journal of emergency medicine, 2014 Mar .

Related studies:

Treatments, associated drugs and conditions:

Diffuse large b-cell lymphoma refractory (2,109 reports)
Febrile neutropenia (78,162 reports)

All the drugs that are associated with Febrile neutropenia:

Febrile neutropenia (1,586 drugs)

All the conditions that are associated with Febrile neutropenia:

Febrile neutropenia (1,875 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Febrile neutropenia and Diffuse large b-cell lymphoma refractory, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.